These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3919001)

  • 1. Primary structure of the reactive site of human C1-inhibitor.
    Salvesen GS; Catanese JJ; Kress LF; Travis J
    J Biol Chem; 1985 Feb; 260(4):2432-6. PubMed ID: 3919001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.
    Brower MS; Harpel PC
    J Biol Chem; 1982 Aug; 257(16):9849-54. PubMed ID: 6980881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase.
    Catanese J; Kress LF
    Biochim Biophys Acta; 1984 Aug; 789(1):37-43. PubMed ID: 6432051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural basis for neutrophil inactivation of C1 inhibitor.
    Pemberton PA; Harrison RA; Lachmann PJ; Carrell RW
    Biochem J; 1989 Feb; 258(1):193-8. PubMed ID: 2930506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of plasma kallikrein and C1-s with normal and dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema: analytic gel studies.
    Donaldson VH; Wagner CJ; Tsuei B; Kindness G; Bing DH; Harrison RA; Rosen FS
    Blood; 1987 Apr; 69(4):1096-101. PubMed ID: 3493816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.
    Nilsson T; Sjöholm I; Wiman B
    Biochem J; 1983 Sep; 213(3):617-24. PubMed ID: 6604523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.
    He S; Sim RB; Whaley K
    Mol Med; 1998 Feb; 4(2):119-28. PubMed ID: 9508789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of human plasma serine proteinase inhibitors (serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases.
    Kress LF
    J Cell Biochem; 1986; 32(1):51-8. PubMed ID: 2429973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cleavage by a Crotalus atrox alpha-proteinase fraction on the properties of C1-inhibitor.
    Patston PA; Qi M; Schifferli JA; Schapira M
    Toxicon; 1995 Jan; 33(1):53-61. PubMed ID: 7778129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A secondary C1s interaction site on C1-inhibitor is essential for formation of a stable enzyme-inhibitor complex.
    He S; Sim RB; Whaley K
    FEBS Lett; 1997 Mar; 405(1):42-6. PubMed ID: 9094421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s.
    Sim RB; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1980 Apr; 612(2):433-49. PubMed ID: 6245704
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.
    Prandini MH; Reboul A; Colomb MG
    Biochem J; 1986 Jul; 237(1):93-8. PubMed ID: 3099750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
    McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the distal hinge region of C1-inhibitor in the regulation of C1s activity.
    He S; Yang JC; Tsang S; Sim RB; Whaley K
    FEBS Lett; 1997 Aug; 412(3):506-10. PubMed ID: 9276455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.
    Wijeyewickrema LC; Lameignere E; Hor L; Duncan RC; Shiba T; Travers RJ; Kapopara PR; Lei V; Smith SA; Kim H; Morrissey JH; Pike RN; Conway EM
    Blood; 2016 Sep; 128(13):1766-76. PubMed ID: 27338096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.
    Aulak KS; Davis AE; Donaldson VH; Harrison RA
    Protein Sci; 1993 May; 2(5):727-32. PubMed ID: 8495195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.